337 related articles for article (PubMed ID: 22406267)
1. Lipid-antigen presentation by CD1d(+) B cells is essential for the maintenance of invariant natural killer T cells.
Bosma A; Abdel-Gadir A; Isenberg DA; Jury EC; Mauri C
Immunity; 2012 Mar; 36(3):477-90. PubMed ID: 22406267
[TBL] [Abstract][Full Text] [Related]
2. Invariant natural killer T cells in lupus patients promote IgG and IgG autoantibody production.
Shen L; Zhang H; Caimol M; Benike CJ; Chakravarty EF; Strober S; Engleman EG
Eur J Immunol; 2015 Feb; 45(2):612-23. PubMed ID: 25352488
[TBL] [Abstract][Full Text] [Related]
3. Aberrant presentation of self-lipids by autoimmune B cells depletes peripheral iNKT cells.
Tan AH; Chong WP; Ng SW; Basri N; Xu S; Lam KP
Cell Rep; 2014 Oct; 9(1):24-31. PubMed ID: 25263549
[TBL] [Abstract][Full Text] [Related]
4. TLR9-induced miR-155 and Ets-1 decrease expression of CD1d on B cells in SLE.
Liu F; Fan H; Ren D; Dong G; Hu E; Ji J; Hou Y
Eur J Immunol; 2015 Jul; 45(7):1934-45. PubMed ID: 25929465
[TBL] [Abstract][Full Text] [Related]
5. The tumor antigen N-glycolyl-GM3 is a human CD1d ligand capable of mediating B cell and natural killer T cell interaction.
Gentilini MV; Pérez ME; Fernández PM; Fainboim L; Arana E
Cancer Immunol Immunother; 2016 May; 65(5):551-62. PubMed ID: 26969612
[TBL] [Abstract][Full Text] [Related]
6. Expansion of invariant natural killer T cells from systemic lupus erythematosus patients by alpha-Galactosylceramide and IL-15.
Hsu CY; Chueh YS; Kuo ML; Lee PT; Hsiao HS; Huang JL; Lin SJ
PLoS One; 2021; 16(12):e0261727. PubMed ID: 34936686
[TBL] [Abstract][Full Text] [Related]
7. Hiding lipid presentation: viral interference with CD1d-restricted invariant natural killer T (iNKT) cell activation.
Horst D; Geerdink RJ; Gram AM; Stoppelenburg AJ; Ressing ME
Viruses; 2012 Oct; 4(10):2379-99. PubMed ID: 23202469
[TBL] [Abstract][Full Text] [Related]
8. The role of iNKT cells in the immunopathology of systemic lupus erythematosus.
Gabriel L; Morley BJ; Rogers NJ
Ann N Y Acad Sci; 2009 Sep; 1173():435-41. PubMed ID: 19758183
[TBL] [Abstract][Full Text] [Related]
9. Identification of distinct human invariant natural killer T-cell response phenotypes to alpha-galactosylceramide.
Croudace JE; Curbishley SM; Mura M; Willcox CR; Illarionov PA; Besra GS; Adams DH; Lammas DA
BMC Immunol; 2008 Dec; 9():71. PubMed ID: 19055753
[TBL] [Abstract][Full Text] [Related]
10. Invariant NKT cells limit activation of autoreactive CD1d-positive B cells.
Wermeling F; Lind SM; Jordö ED; Cardell SL; Karlsson MC
J Exp Med; 2010 May; 207(5):943-52. PubMed ID: 20439539
[TBL] [Abstract][Full Text] [Related]
11. CD1d-dependent endogenous and exogenous lipid antigen presentation.
McEwen-Smith RM; Salio M; Cerundolo V
Curr Opin Immunol; 2015 Jun; 34():116-25. PubMed ID: 25805574
[TBL] [Abstract][Full Text] [Related]
12. Turned on by danger: activation of CD1d-restricted invariant natural killer T cells.
Lawson V
Immunology; 2012 Sep; 137(1):20-7. PubMed ID: 22734667
[TBL] [Abstract][Full Text] [Related]
13. Functions of CD1d-Restricted Invariant Natural Killer T Cells in Antimicrobial Immunity and Potential Applications for Infection Control.
Kinjo Y; Takatsuka S; Kitano N; Kawakubo S; Abe M; Ueno K; Miyazaki Y
Front Immunol; 2018; 9():1266. PubMed ID: 29928278
[TBL] [Abstract][Full Text] [Related]
14. Lipid Antigen Presentation by CD1b and CD1d in Lysosomal Storage Disease Patients.
Pereira CS; Pérez-Cabezas B; Ribeiro H; Maia ML; Cardoso MT; Dias AF; Azevedo O; Ferreira MF; Garcia P; Rodrigues E; Castro-Chaves P; Martins E; Aguiar P; Pineda M; Amraoui Y; Fecarotta S; Leão-Teles E; Deng S; Savage PB; Macedo MF
Front Immunol; 2019; 10():1264. PubMed ID: 31214199
[TBL] [Abstract][Full Text] [Related]
15. Strategy of lipid recognition by invariant natural killer T cells: 'one for all and all for one'.
Mallevaey T; Selvanantham T
Immunology; 2012 Jul; 136(3):273-82. PubMed ID: 22671023
[TBL] [Abstract][Full Text] [Related]
16. Critical role for invariant chain in CD1d-mediated selection and maturation of Vα14-invariant NKT cells.
Sillé FC; Martin C; Jayaraman P; Rothchild A; Besra GS; Behar SM; Boes M
Immunol Lett; 2011 Sep; 139(1-2):33-41. PubMed ID: 21565221
[TBL] [Abstract][Full Text] [Related]
17. Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d-independent manner.
Aoki T; Takami M; Takatani T; Motoyoshi K; Ishii A; Hara A; Toyoda T; Okada R; Hino M; Koyama-Nasu R; Kiuchi M; Hirahara K; Kimura MY; Nakayama T; Shimojo N; Motohashi S
Cancer Sci; 2020 Jul; 111(7):2223-2233. PubMed ID: 32324315
[TBL] [Abstract][Full Text] [Related]
18. Control of CD1d-restricted antigen presentation and inflammation by sphingomyelin.
Melum E; Jiang X; Baker KD; Macedo MF; Fritsch J; Dowds CM; Wang J; Pharo A; Kaser A; Tan C; Pereira CS; Kelly SL; Duan J; Karlsen TH; Exley MA; Schütze S; Zajonc DM; Merrill AH; Schuchman EH; Zeissig S; Blumberg RS
Nat Immunol; 2019 Dec; 20(12):1644-1655. PubMed ID: 31636468
[TBL] [Abstract][Full Text] [Related]
19. Invariant natural killer T cells are enriched at the site of cutaneous inflammation in lupus erythematosus.
Hofmann SC; Bosma A; Bruckner-Tuderman L; Vukmanovic-Stejic M; Jury EC; Isenberg DA; Mauri C
J Dermatol Sci; 2013 Jul; 71(1):22-8. PubMed ID: 23664188
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid induction of CD1d expression primes chronic lymphocytic leukemia B cells for killing by CD8
Ghnewa YG; O'Reilly VP; Vandenberghe E; Browne PV; McElligott AM; Doherty DG
Clin Immunol; 2017 Oct; 183():91-98. PubMed ID: 28780376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
